Aaron Motsoaledi hails historic Pandemic Agreement at G20 Health Summit
Health Minister, Dr Aaron Motsoaledi, has praised the adoption of the Pandemic Agreement during the 4th Health Working Group meeting of the Group of 20 (G20) held in Johannesburg.
This significant international treaty, supported by 124 member states, is only the second international health treaty approved by the World Health Organisation (WHO) since its establishment in 1948.
The agreement's adoption follows three years of intensive negotiation launched due to gaps and inequities identified in the national and global COVID-19 response.
It aims to boost global collaboration to ensure a stronger, more equitable response to future pandemics.
Delivering the welcome address on Tuesday morning, Aaron Motsoaledi celebrated the momentous achievement and emphasised the importance of collective action in ensuring global health security.
'Your presence here today is a testament to our collective commitment to global health security,' he said.
Motsoaledi stated that the agreement results from the diligent efforts of the Intergovernmental Negotiating Body (INB), which was established to develop a legally binding framework for pandemic prevention, preparedness, and response.
'The stark lessons of the COVID-19 crisis fuelled our collective resolve to forge a more robust and equitable framework, one that ensures international cooperation and protects all nations from the devastating impact of future pandemics,' the Minister told the attendees.
South Africa, playing a pivotal leadership role as a co-chair of the INB, worked alongside partners from France and the Netherlands, while acknowledging contributions from vice-chairs representing Brazil, Thailand, Egypt, and New Zealand.
The Minister stated that the four key pillars of the agreement are designed to fundamentally transform the global response to health emergencies.
The agreement emphasises the importance of equitable access to pandemic-related health products, the establishment of a global supply chain and logistics network, and the creation of a coordinating financial mechanism to strengthen pandemic response capabilities.
In addition, the agreement highlights a holistic 'One Health' approach, which stresses the connections between human, animal, and environmental health, which is now a central focus of global pandemic strategies.
The Minister said the agreement incorporates a Pathogen Access and Benefit-Sharing (PABS) system, requiring pharmaceutical companies to contribute 20% of production during pandemics in exchange for access to critical pathogen data.
This mechanism aims to ensure that all nations benefit from scientific advancements, especially in times of crisis.
'As an active participant and representative member for the African region, I can say with certainty that we see this agreement as a crucial step towards rectifying the deep-seated imbalances in access to life-saving pandemic products that were so painfully exposed during the recent crisis.'
Although Aaron Motsoaledi has acknowledged the agreement's adoption as a significant success, there is still much work ahead.
'While we celebrate the adoption of the Pandemic Agreement, our work is far from over. We are now entering a critical new phase.'
He urged immediate engagement in further discussions regarding the PABS system, to convene the Intergovernmental Working Group before 15 July 2025.
'Finalising a robust and equitable PABS annex is the ultimate litmus test of our collective commitment. It is the essential next step to transform the Pandemic Agreement from a document of principles into a functional, life-saving tool for justice and our shared global health security.'
He has since called for continued collaboration and commitment to safeguarding global health for everyone.
This important week-long meeting began this morning and will conclude on Friday, 13 June 2025.
The event brings together health leaders, experts, and policymakers from the world's largest economies, invited nations, and international organisations.
Let us know by leaving a comment below, or send a WhatsApp to 060 011 021 1
Subscribe to The South African website's newsletters and follow us on WhatsApp, Facebook, X and Bluesky for the latest news.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TimesLIVE
9 hours ago
- TimesLIVE
Motsoaledi's big HIV treatment jump: is it true?
Numbers are powerful. They can also be dangerous — if not used correctly. When the health minister said last month that 520,700 extra previously diagnosed people with HIV have started treatment since the end of February, the number sounded astounding. The health department's goal is to find 1.1-million people who know they have HIV, but either never started treatment, or fell out of treatment, before the end of the year. In his words, the department has reached 'more than 50% of the target' they set out to achieve by the end of the year. If that gap is closed, South Africa would have met two of the three so-called 95-95-95 goals the country signed up for as part of the UN plan to end Aids as a public health threat by 2030. However, knowing by exactly how much the gap is closing is tricky, because people who know they have HIV may start and stop and then restart treatment again later — sometimes several times — during the course of their care. In fact, a study from the Western Cape shows that close to half of people on medication stop at least once, and that some even pause and then restart up to three times. So many of the 520,700 previously diagnosed people Motsoaledi says are now on medication could, at least in theory, very well be people who are counted repeatedly as they cycle in and out of treatment. But because the patient information system isn't digitally centralised — most clinics still keep track of their clients on paper, which means different facilities can't easily access one another's records — someone who stops treatment at one clinic can easily be counted as a new start at another, rather than a restart. The set of UN targets aim for 95% of people in a country with HIV to know their diagnosis, 95% of those being on treatment and 95% of those taking medication having such low levels of virus in their bodies that they can't infect someone through sex. 'The reason that we [were] able to reach half a million within a short space of time, was because of weekly check-in meetings with provinces, where reports that come from the ground are verified in the presence of all provincial colleagues before they are regarded as final figures for reporting,' said the minister. But simply counting better isn't the same as doing better, and critics called the reported progress 'inconceivable'. Why? Because for the last few years, the number of people with HIV who have gone on treatment has crept up very slowly, so much so that the gap to 95% has remained more or less the same for about five years. (At the moment just over 80% of people diagnosed with HIV are on treatment.) Moreover, that was while treatment programmes had funding and US-backed money for HIV projects was in place. So now, at a time of funding shortfalls, programmes closing and the government scrambling to plug the holes, could nearly half of the number of people who need to get on treatment really have been added in just 10 weeks? We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2-million people short of its 95%-treatment goal; by 2025 the shortfall will likely be 990,000. That means that the gap — that is, the difference between where the country actually is and where it wants to be when it comes to HIV treatment — has closed by about 210,000.
Mail & Guardian
21 hours ago
- Mail & Guardian
Motsoaledi's big HIV treatment jump: Is it true?
How close is South Africa to meeting its HIV treatment goals? We look at the numbers. (NIAID/Wikimedia) Numbers are powerful. They can also be dangerous if not used correctly. When the The health department's goal is In his words, the department has reached 'more than 50% of the target' they set out to achieve by the end of the year. If that gap is closed, South Africa would have met two of the three But knowing exactly how much the gap is closing is tricky, because people who know they have HIV may start and stop and then restart treatment again later — sometimes several times — during the course of their care. So, many of the 520 700 previously diagnosed people Motsoaledi says are now on medication could, at least in theory, very well be people who are counted repeatedly as they cycle in and out of treatment. But because the patient information system isn't digitally centralised — most clinics still keep track of their clients on paper, which means different facilities can't easily access one another's records — someone who stops treatment at one clinic can easily be counted as a new start at another, rather than a restart. The set of UN targets aim for 95% of people in a country with HIV to know their diagnosis, 95% of those being on treatment and 95% of those taking medication having such low levels of virus in their bodies that they can't infect someone through sex. 'The reason that we [were] able to reach half a million within a short space of time, was because of weekly check-in meetings with provinces, where reports that come from the ground are verified in the presence of all provincial colleagues before they are regarded as final figures for reporting,' said the minister. But simply counting better isn't the same as doing better, and critics called the reported progress Why? Because for the past few years, the number of people with HIV who have gone on treatment has Moreover, that was while treatment programmes had funding and US-backed money for HIV projects was in place. So now, at a time of We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2-million people short of its 95%-treatment goal; by 2025 the shortfall will likely be 990 000. That means that the gap — that is, the difference between where the country actually is and where it wants to be when it comes to HIV treatment — has closed by about 210 000. So there's been progress, but it's been slow: in total, only about 700 000 more people are on HIV medication today than five years ago. 'Getting that last one million or so people on treatment is not simple,' says Kate Rees, public health specialist at the Sometimes people miss an appointment to get a refill of their medicine because they can't afford to take time off work to go to the clinic or they might have moved to another province or district and so they don't go back to the facility where they first got their prescription, she explains. The longer the interruption lasts, the more hesitant people are to go back, says Rees, because they dread Says Rees: 'The health service expects people to be very rigid with their appointments, but life just is not like that.' Slow progress To get a sense of the progress towards meeting the UN's second target in its 95-95-95 cascade, it's best to look at the difference in the total number of people on HIV treatment from year to year, says Leigh Johnson, one of the lead developers of the Although the number of people on medication is increasing, the number grows less and less each year. For example, in 2020, about 291 000 more people were on treatment than in 2019. By 2021, though, the number had grown only by about 225 000. Current forecasts from the model are that the total number of people on treatment will grow by only about 160 000 this year. But that's based on programmes running like they have up to now — and with recent upsets because of US funding cuts, it may be an unreasonable assumption, Johnson says. Part of the reason for the small net gain every year, is that although many people sign up for medication in a year, many also stop coming back to get their scripts refilled. Of those who drop out of treatment, some might choose to restart within a couple of months again, while others may pause their treatment for more than a year. In 2023, for example, roughly 793 500 people who had been on treatment before weren't any longer, but about 728 000 who received medication were restarters, Thembisa numbers show. So even though some people who stop taking their medication might not restart — or restart quickly — the total number who are on treatment still grows; it's just slow-going. This means getting a handle on how close to — or far from — the 95%-treatment mark South Africa is, is more dynamic than simple addition. Stops, starts and restarts 'There will always be people who interrupt their treatment,' says Rees. 'It's not possible to keep everyone perfectly in the system all the time — that's life.' But what's important, she says, is to make those pauses as short as possible by helping people to get back on medication quickly and easily — without judgment. Gesine Meyer-Rath agrees. She's a health economist at Data in the Thembisa model shows that over the years, the number of people starting medication for the first time — in other words, those who have never been on treatment before — has shrunk, but at the same time counts of restarters have grown. Her group's analyses have shown that honing in on keeping people on HIV treatment is the best way to go — But to plan sensibly, she explains, policymakers should know how many people are first-time starters, how many pause treatment but then restart, and how many stop and don't come back at all. 'The more detail programme planners have in the data, the better,' she says. 'The [government's] This is exactly where things can become tricky in future if the holes left by the US funding cuts aren't plugged. Because of the US's aid withdrawal, about 40% of South Africa's HIV data capturers will likely have lost their jobs by September, Says Meyer-Rath: 'The less data we have, the more we're flying blind, which leaves space for bickering over the data that is still there.' This story was produced by the . Sign up for the .
The Citizen
a day ago
- The Citizen
SA highlights strong surveillance as new COVID variant spreads across Asia
South Africa is closely monitoring the emergence of a new COVID-19 variant, known as Nimbus or NB.1.8.1, associated with a rise in cases in certain regions of Asia. This is according to Health Minister Dr Aaron Motsoaledi, who addressed the 4th Health Working Group meeting of the Group of 20 (G20), which is underway in Johannesburg. Motsoaledi said the World Health Organisation (WHO) has designated this 'a variant under monitoring' due to its growing presence. India is the latest country to experience a surge in new COVID-19 cases due to the emergence of the new variant, NB.1.8.1. According to the Independent, infections have been confirmed in several Asian countries, including Thailand, Indonesia and China. In addition, the United Kingdom Health Security Agency reported the first 13 cases of this variant in England last week. 'I wish to reassure this esteemed gathering that South Africa has robust surveillance systems in place. 'Our National Institute for Communicable Diseases (NICD) manages a comprehensive sentinel surveillance programme that systematically tests for key respiratory viruses, including SARS-CoV-2, influenza, and RSV. Currently, our data show very low SARS-CoV-2 activity,' Motsoaledi explained. South Africa is currently experiencing a seasonal rise in influenza, but the country is well-prepared to manage the situation, he said. 'Crucially, the new variant remains a descendant of the Omicron lineage. This means that current recommendations for updated SARS-CoV-2 vaccines are still effective. Therefore, at this stage, no specific new public health actions are required from the public.' Motsoaledi said government continues to promote good hygiene practices, including handwashing, covering coughs, and staying home when feeling unwell. 'These simple measures are effective in reducing the spread of all respiratory illnesses. We will continue to monitor the situation closely through our established networks and will report any significant changes.' Meanwhile, he called on the attendees of the meeting to work together with 'renewed urgency and unwavering resolve'. 'Let us build a future where solidarity, equity, and cooperation are the cornerstones of our global health architecture.' The week-long Health Working Group meeting began on Tuesday and will conclude on Friday. It brings together health leaders, experts, and policymakers from the world's largest economies, invited nations, and international organisations. The plenary sessions will build on lessons learned from the COVID-19 pandemic and address ongoing barriers to accessing countermeasures, particularly in low- and middle-income countries. There will be a focus on prioritising the expansion of local and regional manufacturing capacity, especially in regions like Africa. Delegates will also explore opportunities for technology transfer, sustainable financing, and regulatory alignment to ensure timely and equitable access to life-saving tools during health emergencies. –
